From: Resistin-like molecules: a marker, mediator and therapeutic target for multiple diseases
RELMs | Cell type | Animal type | Stimulator | Signaling pathways | Effector molecules | Effect | Diseases | References |
---|---|---|---|---|---|---|---|---|
RELMα | Rat PMVECs | C57BL/6 mice | NA | NA | VEGF↑, MCP-1↑, SDF-1↑ and VEGFR2↓ | Proliferation and migration of PMVECs, and pulmonary inflammation | PH | [36] |
RELMα | Macrophages of mice and HLFs | HIF-1α+/+ and HIF-1α+/− mice | NA | HIF-1/VEGF-A/VEGFR2 pathway and IKK-β/NF-κB/HIF-1 pathway | HIF-1α↑, VEGF-A↑, VEGFR2↓, NF-κB↑ and IL-6↑ | Pulmonary vascular remodeling, vascular tube formation and BMD cells recruitment and pulmonary inflammation | PH | [37] |
RELMα | NA | RELMα−/−BALB/c mice | OVA | NA | (IL-1β, 1ra, 16, 17; CXCL1, 2, 9, 10, 13; MCP-1; M-CSF; TIMP-1 and TREM-1) ↑ | Pulmonary vascular remodeling and pulmonary inflammation | PH | [38] |
RELMα | Human macrophages | RELMα−/−C57BL/6 mice | NA | HMGB1/RAGE pathway | HMGB1↑ and RAGE↑ | Pulmonary inflammation | PH | [39] |
RELMα | Mouse PMVECs | IL-4 KO C57BL/6 mice | NA | IL-4/IL-4Ri pathway | VEGF↑, MCP-1↑ and SDF-1↑ | Proliferation and migration of PMVECs | PH | [24] |
RELMα | Human PMVECs and human PVSMCs | RELMα KO C57BL/6 J mice | NA | HMGB1/RAGE pathway | HMGB1↑, RAGE↑ and BMPR2↓ | Autophagy, and anti-apoptosis and proliferation of PVSMCs | PH | [53] |
RELMα | Human bone marrow MSCs | RELMα−/− BALB/c mice | NA | PI3K/Akt pathway and ERK1/2 pathway | p-Akt↑ and p-ERK1/2↑ | Proliferation of non-hematopoietic progenitor cells and MSCs | PH | |
RELMα | Neonatal rat cardiomyocytes | SD rats | NA | PGC-1α/PPARα/ERRα pathway | PGC-1α↓, PPARα↓, ERRα↓, TFAM↓, Top1mt↓, POLG2↓, Polrmt↓, LCAD↓, VLCAD↓, ACADM↓, ACADS↓, Cpt-1a↓ and Cpt-1b↓ | Mediating cardiac energy metabolism and mitochondrial structure, biogenesis and function | PH and right ventricular hypertrophy | [74] |
RELMα | NA | Retnla-Tg mice | OVA | NA | Muc5ac↓, IL-4↓, IL-5↓, IL-13↓ and p-ERK1/2↓ | Preventing allergic lung inflammation | Asthma | [78] |
RELMα | Rat AECII and Rat lung fibroblasts | Wistar rats and Fisher 344 rats | OVA and BLM | NA | α-SMA↑and collagen type I↑ | Myofibroblast differentiation | Pulmonary fibrosis and asthma | |
RELMα | BECs | RELMα−/− C57BL/6 mice | OSM | NA | COL1A1↑, COL3A1↑, MMP13↑ and TIMP1↑ | ECM remodelling | Pulmonary fibrosis | [84] |
RELMα | NA | SD Rat | L-arginine and sodium taurocholate | NA | p-Akt↑, p-NF-κB↑, p-p38 MAPK↑, p-ERK↑, ICAM-1↑, IL-1β↑, IL-6↑, IL-8↑, TNF-α↑ and CRP↑ | Inflammation and lung injury | APALI | [40] |
RELMα | NA | BALB/c mice and BL/6 mice | N. brasiliensis | NA | IL-17A↓ | Limiting emphysema | Emphysema | [42] |
RELMα | NA | RELMα−/− C57BL/6 mice | S. mansoni eggs | BTK pathway | IL-4↓, IL-5↓ and IL-13↓ | Limiting pulmonary inflammation | NA | [41] |
RELMα | NA | RELMα−/− and IL-17A−/− C57BL/6 mice | C. rodentium | IL-23p19/IL-17A pathway | IL-23p19↑ and IL-17A↑ | Intestinal inflammation | Intestinal inflammation | |
RELMα | BMD macrophage | RELMα−/− C57BL/6 or BALB/c mice | DSS | NA | IL-5↑, IL-6↑, IL-10↓, IL-17↑, TNF-α↑, CCL5↑, CCL11↑, p-NF-κB↑, p-ERK1/2↑ and p-p38 MAPK↑ | Colitis | Colitis | |
RELMα | NA | RELMα−/− and RELMβ−/− mice | N. brasiliensis | Fc receptor signaling and STAT6 pathway | IL-4↓, IL-13↓ and IL-17A↓ | Downregulating lung inflammation and delaying parasite expulsion | Hookworm Infection | |
RELMα | Murine myoblast cell and human endothelial progenitor cell | NA | NA | PDK1/PI3K/Akt/c-Jun pathway | p-PDK1↑, p-PI3K↑, p-Akt↑, p–c-Jun↑ and IL-18↑ | Formation of endothelial progenitor cell tube and angiogenesis | Inflammatory myopathy | [106] |
RELMα | Mouse eosinophils and mouse epithelial cells | CC10-rtTA-RELMα bitransgenic mice | DOX | NA | NA | Epithelial cell hyperplasia and basal layer thickness | EoE | [56] |
RELMα | VSMCs of rat | ApoE–/–C57BL/6 J mice | High fat | NA | NA | Proliferation and migration of VSMCs | Atherosclerosis | [102] |
RELMα | Murine AML-12 cells and peritoneal macrophage of mice | Retnla−/− C57BL/6 J mice, Ldlr−/−Retnla−/− mice and Retnla-Tg mice | High fat | Lrh-1/CYP7A1 pathway | Lrh-1↑, CYP7A1↑ and VLDL cholesterol↓ | Increasing excretion of cholesterol in the form of bile acids | Hypercholesterolaemia and atherosclerosis | [20] |
RELMα | Mouse macrophages | ApoE−/− mice | Ang II | ERK1/2 pathway and JNK pathway | MCP-1↑, IL-6↑, MMP-2↑, MMP-9↑, p-ERK1/2↑ and p-JNK↑ | Vascular inflammation | Abdominal aortic aneurysm | [107] |
RELMα | Gastric cancer cells | Human | NA | NF-κB-MMP-9/VEGF pathway | NF-κB↑, VEGF↑ and MMP-9↑ | Proliferation, migration and invasion of gastric cancer cells | Gastric cancer | [108] |